Cecelia Koetting, OD, FAAO, DipABO

Cecelia Koetting, OD, FAAO, DIpABO, details her poster presentation at AAOpt's Academy 2025 meeting.

Cecelia Koetting, OD, FAAO, DipABO, emphasized that the field of regenerative medicine is continuously expanding, with new devices and approaches constantly emerging.

A conversation with survivor and advocate Jasmine Grace Marino.

The surgery isn't over until the healing is don

CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.

Cecelia Koetting, OD, FAAO, DipABO, and Madeline Yung, MD, discussed emerging treatment and patient care options for those with presbyopia during CRU 2025.

Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.

Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.

An overview of prescription medications available for DED.

EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.

EnVision Summit optometry faculty Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.

Key takeaways from the past year that can help optometrists look ahead to 2025.

Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent study that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.

Resolving eye care disparities can yield positive results for patients of all backgrounds.

Technological advancements may improve treatment options.

A travel in time and across the world shows the development of refractive surgery and how eye care providers can play a part in the future of pre- and postoperative refractive surgery care.

Cecelia Koetting, OD, FAAO, DIPABO chats with Optometry Times about her role with EnVision Summit's new optometry program and the excitement surrounding the event.

Even if DLS is completely normal and expected, it can be mentally and emotionally difficult for patients.

Results of the BRIO-I study, the first of 2 phase 3 clinical trials of Brimochol PF, a topical, fixed-dose combination for the treatment of presbyopia, have recently been released.

Cecelia Koetting, OD, FAAO, shares insights from her AOA 2023 presentation on Demodex diaries.

Provide better, more cohesive patient care with comanagement.

The ones you should seek out—and avoid.

Intact corneal tissue can be reused for preservation and reimplantation.

FDA-approved steroid offers short-term relief for ocular surface inflammation.

Evaluating patients’ eyelids before cataract and refractive surgery is crucial, as ptosis can create unwanted adverse effects and alter outcomes.

Dr. Koetting asks: When do you feel it is time to discuss cataracts with your patients?

During AOA 2022, Cecelia Koetting, OD, FAAO, shares highlights from her presentation titled "Ocular Surgeries and the Role of the Paraoptometric."

Posterior chamber pIOLs should be considered for patients in which other refractive surgeries may not be an option and as an reversible alternative with fewer complications.

What to ask when triaging a patient